Concepedia

F. Marmé

FM

2

Publications

117

Citations

2

H-Index

2016

Active since

Affiliations

Heidelberg University(Current)

University Hospital Heidelberg

F. Marmé is an author at Heidelberg University specializing in oncology, cancer therapeutics, and radiation oncology.

Top concepts

Publications per year

2016–2022

2

Publications

2

A phase I trial of the trifunctional anti Her2 × anti CD3 antibody ertumaxomab in patients with advanced solid tumors

Nicole Haense, Akin Atmaca, Claudia Pauligk et al. · BMC Cancer · 2016 · 62 citations · Full text

LBA76 Overall survival (OS) results from the phase III TROPiCS-02 study of sacituzumab govitecan (SG) vs treatment of physician's choice (TPC) in patients (pts) with HR+/HER2- metastatic breast cancer (mBC)

Hope S. Rugo, A. Bardia, F. Marmé et al. · Annals of Oncology · 2022 · 55 citations · Full text

, , +4

Rows per page

1–2 of 2